The Epidermal Growth Factor Receptor (EGFR/ErbB) receptor tyrosine kinase (RTK) family has been implicated in numerous cancer types (e.g. lung, breast and brain) and this signaling network is conserved from Drosophila to humans. For this reason, Drosophila may provide an ideal in vivo system for experimental analyses of this pathway and a chemical genetics approach to the identification of therapeutics against it. Towards this goal, an assay utilizing Drosophila transgenic for members of the human ErbB family was developed for screening putative inhibitory compounds. Preliminary phenotypic data with known EGFR inhibitors yielded promising results.

• This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.

Creator

• Buck, Cassandra J.

Publisher

• Worcester Polytechnic Institute

Identifier

• E-project-042607-122222

Advisor

• Duffy, Joseph B.

Year

• 2007

Date created

• 2007-04-26

Resource type

• Major Qualifying Project

Major

• Biology & Biotechnology

Rights statement

• In Copyright

Last modified

• 2020-11-23